{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T19:12:26Z","timestamp":1782414746786,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Nebraska Department of Health and Human Services,United States","award":["Nebraska Laws 2021, LB 380, Section 109"],"award-info":[{"award-number":["Nebraska Laws 2021, LB 380, Section 109"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Components of the hypothalamic-pituitary axis (HPA) pathway are potential mediators of the genetic risk of polycystic ovarian syndrome (PCOS). Impaired glucocorticoid receptor (<jats:italic>NR3C1<\/jats:italic>) expression and function may underlie impaired HPA-axis cortisol activity, thereby also contributing to the increased adrenal cortisol and androgen production present in women with PCOS. In this study, we aimed to identify whether <jats:italic>NR3C1<\/jats:italic> is linked or in linkage disequilibrium (LD), that is, linkage joint to association, with PCOS in Italian peninsular families.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>In 212 Italian families with type 2 diabetes (T2D) from the Italian peninsula, previously recruited for a T2D study and phenotyped for PCOS, we used microarray to genotype 25 variants in the <jats:italic>NR3C1<\/jats:italic> gene. We analyzed the 25 <jats:italic>NR3C1<\/jats:italic> variants by Pseudomarker parametric linkage and LD analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found the novel implication in PCOS risk of two intronic variants located within the <jats:italic>NR3C1<\/jats:italic> gene (rs10482672 and rs11749561), thereby extending the phenotypic implication related to impaired glucocorticoid receptor.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>To the best of our knowledge, this is the first study to report <jats:italic>NR3C1<\/jats:italic> as a risk gene in PCOS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-023-01329-5","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T09:02:36Z","timestamp":1705050156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The glucocorticoid receptor gene (NR3C1) is linked to and associated with polycystic ovarian syndrome in Italian families"],"prefix":"10.1186","volume":"17","author":[{"given":"Shumail","family":"Syed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Gragnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"issue":"6","key":"1329_CR1","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1210\/endrev\/bnac001","volume":"43","author":"M Dapas","year":"2022","unstructured":"Dapas M, Dunaif A. Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification. Endocr Rev. 2022;43(6):927\u201365.","journal-title":"Endocr Rev"},{"issue":"2","key":"1329_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/obr.12762","volume":"20","author":"SS Lim","year":"2019","unstructured":"Lim SS, et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev. 2019;20(2):339\u201352.","journal-title":"Obes Rev"},{"issue":"2","key":"1329_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","volume":"132","author":"R Azziz","year":"2018","unstructured":"Azziz R. Polycystic ovary syndrome. Obstet Gynecol. 2018;132(2):321\u201336.","journal-title":"Obstet Gynecol"},{"issue":"11","key":"1329_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11920-017-0834-2","volume":"19","author":"LG Cooney","year":"2017","unstructured":"Cooney LG, Dokras A. Depression and anxiety in polycystic ovary syndrome: etiology and treatment. Curr Psychiatry Rep. 2017;19(11):83.","journal-title":"Curr Psychiatry Rep"},{"key":"1329_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1196\/annals.1367.006","volume":"1083","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Economou F. Stress in women: metabolic syndrome and polycystic ovary syndrome. Ann N Y Acad Sci. 2006;1083:54\u201362.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"1329_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0889-8529(05)70070-0","volume":"28","author":"RL Rosenfield","year":"1999","unstructured":"Rosenfield RL. Ovarian and adrenal function in polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1999;28(2):265\u201393.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"1329_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/10253890.2018.1470238","volume":"21","author":"JK Gjerstad","year":"2018","unstructured":"Gjerstad JK, Lightman SL, Spiga F. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility. Stress. 2018;21(5):403\u201316.","journal-title":"Stress"},{"issue":"6","key":"1329_CR8","doi-asserted-by":"publisher","first-page":"941","DOI":"10.4158\/EP11061.RA","volume":"17","author":"G Briassoulis","year":"2011","unstructured":"Briassoulis G, et al. The glucocorticoid receptor and its expression in the anterior pituitary and the adrenal cortex: a source of variation in hypothalamic-pituitary-adrenal axis function; implications for pituitary and adrenal tumors. Endocr Pract. 2011;17(6):941\u20138.","journal-title":"Endocr Pract"},{"issue":"11","key":"1329_CR9","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1080\/09513590.2021.1908254","volume":"37","author":"JJ Benjamin","year":"2021","unstructured":"Benjamin JJ, et al. Cortisol and polycystic ovarian syndrome - a systematic search and meta-analysis of case-control studies. Gynecol Endocrinol. 2021;37(11):961\u20137.","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"1329_CR10","doi-asserted-by":"publisher","first-page":"bvaa111","DOI":"10.1210\/jendso\/bvaa111","volume":"4","author":"A Panayiotopoulos","year":"2020","unstructured":"Panayiotopoulos A, et al. Glucocorticoid Resistance in premature Adrenarche and PCOS: from childhood to Adulthood. J Endocr Soc. 2020;4(9):bvaa111.","journal-title":"J Endocr Soc"},{"issue":"10","key":"1329_CR11","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1055\/s-0031-1283122","volume":"119","author":"DV Milutinovi\u0107","year":"2011","unstructured":"Milutinovi\u0107 DV, et al. Hypothalamic-pituitary-adrenocortical axis hypersensitivity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2011;119(10):636\u201343.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"1329_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.6061\/clinics\/2014(03)06","volume":"69","author":"GA Maciel","year":"2014","unstructured":"Maciel GA, et al. Association of glucocorticoid receptor polymorphisms with clinical and metabolic profiles in polycystic ovary syndrome. Clin (Sao Paulo). 2014;69(3):179\u201384.","journal-title":"Clin (Sao Paulo)"},{"issue":"6","key":"1329_CR13","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1365-2265.2008.03175.x","volume":"68","author":"AA Syed","year":"2008","unstructured":"Syed AA, et al. A common intron 2 polymorphism of the glucocorticoid receptor gene is associated with insulin resistance in men. Clin Endocrinol (Oxf). 2008;68(6):879\u201384.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1329_CR14","doi-asserted-by":"crossref","unstructured":"Xu Y, Qiao J. Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature J Healthc Eng, 2022. 2022: p.\u00a09240569.","DOI":"10.1155\/2022\/9240569"},{"key":"1329_CR15","doi-asserted-by":"crossref","unstructured":"Amin M et al. Familial linkage and association of the NR3C1 gene with type 2 Diabetes and Depression Comorbidity. Int J Mol Sci, 2022. 23(19).","DOI":"10.3390\/ijms231911951"},{"key":"1329_CR16","doi-asserted-by":"crossref","unstructured":"Rotterdam EA. .-S.P.c.w.g., revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137.","DOI":"10.1093\/humrep\/deh098"},{"issue":"3","key":"1329_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559\u201375.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1329_CR18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000329467","volume":"71","author":"T Hiekkalinna","year":"2011","unstructured":"Hiekkalinna T, et al. PSEUDOMARKER: a powerful program for joint linkage and\/or linkage disequilibrium analysis on mixtures of singletons and related individuals. Hum Hered. 2011;71(4):256\u201366.","journal-title":"Hum Hered"},{"issue":"D1","key":"1329_CR19","doi-asserted-by":"publisher","first-page":"D139","DOI":"10.1093\/nar\/gkw1064","volume":"45","author":"S Kumar","year":"2017","unstructured":"Kumar S, Ambrosini G, Bucher P. SNP2TFBS - a database of regulatory SNPs affecting predicted transcription factor binding site affinity. Nucleic Acids Res. 2017;45(D1):D139\u2013d144.","journal-title":"Nucleic Acids Res"},{"key":"1329_CR20","doi-asserted-by":"crossref","unstructured":"Xu Z, Taylor JA. SNPinfo: Integrating GWAS and candidate gene information into functional SNP selection for genetic association studies Nucleic Acids Research, 2009. 37(SUPPL. 2).","DOI":"10.1093\/nar\/gkp290"},{"issue":"1","key":"1329_CR21","first-page":"1","volume":"2012 13","author":"C Liu","year":"2012","unstructured":"Liu C, et al. MirSNP, a database of polymorphisms altering miRNA target sites, identifies miRNA-related SNPs in GWAS SNPs and eQTLs. BMC Genomics. 2012;2012 13(1):1\u201310.","journal-title":"BMC Genomics"},{"issue":"9","key":"1329_CR22","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1101\/gr.137323.112","volume":"22","author":"AP Boyle","year":"2012","unstructured":"Boyle AP, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22(9):1790\u20137.","journal-title":"Genome Res"},{"issue":"9","key":"1329_CR23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.tips.2013.07.003","volume":"34","author":"M Kadmiel","year":"2013","unstructured":"Kadmiel M, Cidlowski JA. Glucocorticoid receptor signaling in health and Disease. Trends Pharmacol Sci. 2013;34(9):518\u201330.","journal-title":"Trends Pharmacol Sci"},{"key":"1329_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1749-6632.1998.tb09546.x","volume":"840","author":"BS McEwen","year":"1998","unstructured":"McEwen BS. Stress, adaptation, and Disease. Allostasis and allostatic load. Ann N Y Acad Sci. 1998;840:33\u201344.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"1329_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrn1683","volume":"6","author":"ER de Kloet","year":"2005","unstructured":"de Kloet ER, Jo\u00ebls M, Holsboer F. Stress and the brain: from adaptation to Disease. Nat Rev Neurosci. 2005;6(6):463\u201375.","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"1329_CR26","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.soard.2018.07.032","volume":"14","author":"RW O\u2019Rourke","year":"2018","unstructured":"O\u2019Rourke RW. Adipose tissue and the physiologic underpinnings of metabolic Disease. Surg Obes Relat Dis. 2018;14(11):1755\u201363.","journal-title":"Surg Obes Relat Dis"},{"issue":"11","key":"1329_CR27","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1007\/s43032-021-00765-2","volume":"29","author":"JV Kolhe","year":"2022","unstructured":"Kolhe JV, et al. PCOS and depression: common links and potential targets. Reprod Sci. 2022;29(11):3106\u201323.","journal-title":"Reprod Sci"},{"issue":"1","key":"1329_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4239\/wjd.v13.i1.5","volume":"13","author":"S Livadas","year":"2022","unstructured":"Livadas S, et al. Polycystic ovary syndrome and type 2 Diabetes Mellitus: a state-of-the-art review. World J Diabetes. 2022;13(1):5\u201326.","journal-title":"World J Diabetes"},{"issue":"6","key":"1329_CR29","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/S0015-0282(00)01620-4","volume":"74","author":"M Kahsar-Miller","year":"2000","unstructured":"Kahsar-Miller M, et al. A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome. Fertil Steril. 2000;74(6):1237\u201340.","journal-title":"Fertil Steril"},{"issue":"10","key":"1329_CR30","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1093\/humrep\/der222","volume":"26","author":"O Valkenburg","year":"2011","unstructured":"Valkenburg O, et al. Genetic polymorphisms of the glucocorticoid receptor may affect the phenotype of women with anovulatory polycystic ovary syndrome. Hum Reprod. 2011;26(10):2902\u201311.","journal-title":"Hum Reprod"},{"key":"1329_CR31","doi-asserted-by":"crossref","unstructured":"Deeb SS, Brunzell JD. The role of the PGC1\u03b1 Gly482Ser polymorphism in weight gain due to intensive diabetes therapy PPAR Res, 2009. 2009: p.\u00a0649286.","DOI":"10.1155\/2009\/649286"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01329-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01329-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01329-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T09:05:37Z","timestamp":1705050337000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01329-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1329"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01329-5","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]},"assertion":[{"value":"18 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"C.G. is Professor of Medicine, Chief of Endocrinology, Endowed Puller Chair, Creighton University School of Medicine, Omaha, NE, and Adjunct Professor of Public Health Sciences, Penn State University College of Medicine, Hershey, PA; S.S. in an MD, graduated Endocrinology Fellow, Creighton University School of Medicine, Omaha, NE.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}}],"article-number":"13"}}